Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-06-02 Purchase |
2023-06-06 9:00 pm |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
30,000 | $0.431 | $12,930 | 1,327,174 (Direct) |
View |
2022-10-17 Purchase |
2022-10-19 5:29 pm |
Pasithea Therapeutics Corp. | KTTA | Delaney David Concord IP2 Ltd. Elderhill Corp Member of 10% owner group |
1,000 | $1.11 | $1,110 | 227,521 (Indirect) |
View |
2022-09-28 Purchase |
2022-09-30 4:36 pm |
Pasithea Therapeutics Corp. | KTTA | Shahinian Eric Camac Capital LLC Camac Fund LP Camac Partners LLC Member of 10% owner group |
64,357 | $1.1856 | $76,299 | 1,788,415 (Indirect) |
View |
2022-09-01 Purchase |
2022-09-06 5:03 pm |
Pasithea Therapeutics Corp. | KTTA | Shahinian Eric Camac Capital LLC Camac Fund LP Camac Partners LLC Member of 10% owner group |
88,901 | $1.129 | $100,367 | 1,724,058 (Indirect) |
View |
2022-08-29 Purchase |
2022-08-31 4:32 pm |
Pasithea Therapeutics Corp. | KTTA | Shahinian Eric Camac Capital LLC Camac Fund LP Camac Partners LLC Member of 10% owner group |
22,828 | $1.1518 | $26,293 | 1,635,157 (Indirect) |
View |
2022-08-19 Purchase |
2022-08-26 4:30 pm |
Pasithea Therapeutics Corp. | KTTA | Geller Avi Leonite Fund I LP Leonite Capital LLC Member of 10% owner group |
54,644 | $1.2982 | $70,939 | 1,089,346 (Indirect) |
View |
2022-08-17 Purchase |
2022-08-18 7:35 pm |
Pasithea Therapeutics Corp. | KTTA | Shahinian Eric Camac Capital LLC Camac Fund LP Camac Partners LLC Member of 10% owner group |
155,773 | $1.2087 | $188,283 | 1,611,329 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-12 Option Award |
2024-06-14 5:25 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director |
750 | $5.61 | 3,500 (Direct) |
View |
2024-06-13 Option Award |
2024-06-14 5:25 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director |
2,750 | $5.62 | 3,500 (Direct) |
View |
2024-03-01 Option Award(A) |
2024-04-05 9:45 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
26,669 | $0 | 26,669 (Direct) |
View |
2024-03-01 Option Award(A) |
2024-04-05 9:45 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director |
7,500 | $0 | 7,500 (Direct) |
View |
2024-03-01 Option Award(A) |
2024-04-05 9:45 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer |
15,927 | $0 | 15,927 (Direct) |
View |
2024-03-01 Option Award(A) |
2024-04-05 9:45 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Leahy Emer Director |
7,500 | $0 | 7,500 (Direct) |
View |
2024-03-01 Option Award(A) |
2024-04-05 9:45 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director |
5,000 | $0 | 5,000 (Direct) |
View |
2024-03-01 Option Award(A) |
2024-04-05 9:45 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Currie Graeme Martin Chief Development Officer |
5,938 | $0 | 5,938 (Direct) |
View |
2024-03-01 Option Award(A) |
2024-04-05 9:45 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
7,500 | $0 | 7,500 (Direct) |
View |
2024-03-01 Option Award |
2024-03-01 9:47 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
7,500 | $0 | 7,500 (Direct) |
View |
2024-03-01 Option Award |
2024-03-01 9:46 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer |
15,927 | $0 | 15,927 (Direct) |
View |
2024-03-01 Option Award |
2024-03-01 9:46 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director |
5,000 | $0 | 5,000 (Direct) |
View |
2024-03-01 Option Award |
2024-03-01 9:46 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
26,669 | $0 | 26,669 (Direct) |
View |
2024-03-01 Option Award |
2024-03-01 9:46 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Leahy Emer Director |
7,500 | $0 | 7,500 (Direct) |
View |
2024-03-01 Option Award |
2024-03-01 9:45 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director |
7,500 | $0 | 7,500 (Direct) |
View |
2024-03-01 Option Award |
2024-03-01 9:45 pm |
N/A 2034-02-28 |
Pasithea Therapeutics Corp. | KTTA | Currie Graeme Martin Chief Development Officer |
5,938 | $0 | 5,938 (Direct) |
View |
Ownership |
2023-07-03 5:00 pm |
2023-06-30 2033-02-23 |
Pasithea Therapeutics Corp. | KTTA | Currie Graeme Martin Chief Development Officer |
0 | $0 | 300,000 (Direct) |
View |
Ownership |
2023-02-14 6:15 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | PD Joint Holdings LLC Series 2016-A Manning Paul B Manning Bradford Tiger Lily Capital LLC 10% Owner |
0 | $0 | 3,408,696 (Direct) |
View |
2022-11-28 Option Award |
2022-11-28 4:00 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $0.98 | 1,287,174 (Direct) |
View |
2022-11-23 Option Award |
2022-11-28 4:00 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
5,000 | $1 | 819,206 (Direct) |
View |
2022-11-23 Option Award |
2022-11-28 4:00 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
1,206 | $1.02 | 819,206 (Direct) |
View |
2022-11-23 Option Award |
2022-11-28 4:00 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
3,000 | $1.03 | 819,206 (Direct) |
View |
2022-11-22 Option Award |
2022-11-22 4:10 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $0.99 | 1,282,174 (Direct) |
View |
2022-11-17 Option Award |
2022-11-17 4:34 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director |
40,000 | $1.06 | 150,000 (Direct) |
View |
2022-11-15 Option Award |
2022-11-17 4:34 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director |
10,000 | $1.07 | 150,000 (Direct) |
View |
2021-08-02 Option Award |
2022-11-17 4:34 pm |
2022-08-02 2031-08-02 |
Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director |
100,000 | $0 | 150,000 (Direct) |
View |
2022-10-26 Option Award |
2022-10-26 5:35 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $1.1 | 1,277,174 (Direct) |
View |
2022-10-21 Option Award |
2022-10-24 10:15 am |
2023-10-21 2032-10-21 |
Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director |
100,000 | $0 | 100,000 (Direct) |
View |
2022-10-21 Option Award |
2022-10-21 5:05 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
4,400 | $1.07 | 810,000 (Direct) |
View |
2022-10-21 Option Award |
2022-10-21 5:05 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
600 | $1.08 | 810,000 (Direct) |
View |
2022-10-17 Option Award |
2022-10-17 6:11 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
9,000 | $1.13 | 1,272,174 (Direct) |
View |
2022-10-17 Option Award |
2022-10-17 6:11 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
1,000 | $1.14 | 1,272,174 (Direct) |
View |
2022-10-11 Option Award |
2022-10-12 8:15 pm |
2023-10-11 2032-10-11 |
Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
Ownership |
2022-08-16 5:56 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Delaney David Concord IP2 Ltd. Elderhill Corp Member of 10% owner group |
0 | $0 | 226,521 (Indirect) |
View |
Ownership |
2022-08-15 06:13 am |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Shahinian Eric Camac Capital LLC Camac Fund LP Camac Partners LLC Member of 10% owner group |
0 | $0 | 1,455,556 (Indirect) |
View |
Ownership |
2022-08-15 06:12 am |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Geller Avi Leonite Capital LLC Member of 10% owner group 10% Owner |
0 | $0 | 1,034,702 (Indirect) |
View |